Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Artelo Biosciences Inc.

    NASDAQ: ARTL · Real-Time Price · USD
    9.33
    -3.94 (-29.69%)
    At close: Jul 01, 2025, 3:59 PM
    10.11
    8.36%
    Pre-market: Jul 02, 2025, 08:52 AM EDT

    Artelo Biosciences Statistics

    Share Statistics

    Artelo Biosciences has 546.67K shares outstanding. The number of shares has increased by -83.06% in one year.

    Shares Outstanding

    n/a
    		 546.67K

    Shares Change (YoY)

    n/a
    		 -83.06%

    Shares Change (QoQ)

    n/a
    		 -83.34%

    Owned by Institutions (%)

    n/a
    		 3.26%

    Shares Floating

    n/a
    		 542.14K

    Failed to Deliver (FTD) Shares

    n/a
    		 939

    FTD / Avg. Volume

    n/a
    		 0.18%

    Short Selling Information

    The latest short interest is 11.79K, so 2.16% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 11.79K

    Short % of Shares Out

    n/a
    		 2.16%

    Short % of Float

    n/a
    		 2.18%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -0.83 and the forward PE ratio is -4.21. Artelo Biosciences's PEG ratio is 0.02.

    PE Ratio

    n/a
    		 -0.83

    Forward PE

    n/a
    		 -4.21

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 0.42

    P/FCF Ratio

    n/a
    		 -1.02

    PEG Ratio

    n/a
    		 0.02
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Artelo Biosciences.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 18.36, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 18.36

    Quick Ratio

    n/a
    		 18.36

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 -0.01

    Debt / FCF

    n/a
    		 -0.01

    Interest Coverage

    n/a
    		 -2057.4

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,680,500

    Employee Count

    n/a
    		 6

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -209K

    Effective Tax Rate

    n/a
    		 2.07%

    Stock Price Statistics

    The stock price has increased by 17.8% in the last 52 weeks. The beta is 1.03, so Artelo Biosciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.03

    52-Week Price Change

    n/a
    		 17.8%

    50-Day Moving Average

    n/a
    		 6.42

    200-Day Moving Average

    n/a
    		 6.55

    Relative Strength Index (RSI)

    n/a
    		 60.64

    Average Volume (20 Days)

    n/a
    		 515,621

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -10.29M

    Net Income

    n/a
    		 -10.08M

    EBITDA

    n/a
    		 -10.29M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 -3.49
    Full Income Statement

    Balance Sheet

    The company has 6.89M in cash and 63K in debt, giving a net cash position of 6.83M.

    Cash & Cash Equivalents

    n/a
    		 6.89M

    Total Debt

    n/a
    		 63K

    Net Cash

    n/a
    		 6.83M

    Retained Earnings

    n/a
    		 -31.02M

    Total Assets

    n/a
    		 15.5M

    Working Capital

    n/a
    		 12.51M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -8.01M and capital expenditures 0, giving a free cash flow of -8.01M.

    Operating Cash Flow

    n/a
    		 -8.01M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -8.01M

    FCF Per Share

    n/a
    		 -16.97
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    ARTL does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for ARTL is $33, which is 253.7% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $33

    Price Target Difference

    n/a
    		 253.7%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jun 13, 2025. It was a backward split with a ratio of 1:6.

    Last Split Date

    n/a
    		 Jun 13, 2025

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:6

    Scores

    Altman Z-Score

    n/a
    		 -2.06

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist